Results
74,179 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 21 |  April McClain DelaneyDDependent child |  CHRWC. H. ROBINSON WORLDWIDE, INC.Purchase | BUY | $1,001 – $15K |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 21 | April McClain DelaneyDDependent child | CHRWC. H. ROBINSON WORLDWIDE, INC. Purchase | BUY | $1,001 – $15K |
| Sep 9, 2026 traded Aug 5, 2026 |
| 21 | April McClain DelaneyDDependent child |  HUBBHUBBELL INCPurchase | BUY | $1,001 – $15K | Sep 9, 2026 traded Aug 3, 2026 |
| 21 | Higgins John GerardChief, Client &Partner Success |  PEGAPEGASYSTEMS INCOption exercise | M | — 2,280 sh | Sep 9, 2026 traded Sep 7, 2026 |
| 21 | April McClain DelaneyDDependent child |  WABWESTINGHOUSE AIR BRAKE TECHNOLOGIES CORPPartial sale | SELL | $15K – $50K | Sep 9, 2026 traded Aug 3, 2026 |
| 21 | April McClain DelaneyDDependent child |  BWXTBWX Technologies, Inc.Purchase | BUY | $1,001 – $15K | Sep 9, 2026 traded Aug 3, 2026 |
| 21 | April McClain DelaneyDDependent child | HUBBHUBBELL INC Purchase | BUY | $15K – $50K | Sep 9, 2026 traded Aug 19, 2026 |
| 21 | Cutler David GChief Technology Officer |  EYENational Vision Holdings, Inc.Option exercise | M | — 13.0K sh | Sep 9, 2026 traded Sep 8, 2026 |
| 21 | Purcell Lynn SebastianDirector, 10% Owner |  CNXUConexeu Sciences Inc.In-the-money exercise | X | $500K 217.6K sh | Sep 9, 2026 traded Sep 4, 2026 |
| 21 | Budur KumarCHIEF MEDICAL OFFICER |  HRMYHarmony Biosciences Holdings, Inc.Open-market sale | SELL | $43K 1,000 sh | Sep 9, 2026 traded Sep 8, 2026 |
| 21 | April McClain DelaneyDDependent child |  LTHLife Time Group Holdings, Inc.Purchase | BUY | $1,001 – $15K | Sep 9, 2026 traded Aug 6, 2026 |
| 21 | April McClain DelaneyDDependent child | LTHLife Time Group Holdings, Inc. Purchase | BUY | $1,001 – $15K | Sep 9, 2026 traded Aug 7, 2026 |
| 21 | Carter Philip MatthewSVP & Chief Financial Officer |  SWKSSKYWORKS SOLUTIONS, INC.Option exercise | M | — 9,917 sh | Sep 9, 2026 traded Sep 8, 2026 |
| 21 | Tiran AssafEVP Cross Suez & Atlantic BU |  ZIMZIM Integrated Shipping Services Ltd.Option exercise | M | — 16.0K sh | Sep 9, 2026 traded Sep 8, 2026 |
| 20 |  Maria Elvira SalazarRSelf |  MRNAModerna, Inc.Partial sale | SELL | $1,001 – $15K | Sep 9, 2026 traded Aug 19, 2026 |
| 20 |  Cory A. BookerDSpouse |  ALNYALNYLAM PHARMACEUTICALS, INC.Sale (Full) | SELL | $1,001 – $15K | Sep 9, 2026 traded Aug 11, 2026 |
| 20 | April McClain DelaneyDDependent child |  LHLABCORP HOLDINGS INC.Partial sale | SELL | $1,001 – $15K | Sep 9, 2026 traded Aug 7, 2026 |
| 20 | April McClain DelaneyDDependent child |  ESEESCO TECHNOLOGIES INCPurchase | BUY | $1,001 – $15K | Sep 9, 2026 traded Aug 24, 2026 |
| 20 | April McClain DelaneyDDependent child | ESEESCO TECHNOLOGIES INC Purchase | BUY | $1,001 – $15K | Sep 9, 2026 traded Aug 20, 2026 |
| 20 | April McClain DelaneyDDependent child | LHLABCORP HOLDINGS INC. Partial sale | SELL | $1,001 – $15K | Sep 9, 2026 traded Aug 6, 2026 |
| 20 | Azamian Bobak R.Director, President/CEO and Board Chair |  TARSTarsus Pharmaceuticals, Inc.Open-market sale · 10b5-1 plan | SELL | $265K 2,900 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 20 | April McClain DelaneyDDependent child |  TDYTELEDYNE TECHNOLOGIES INCPartial sale | SELL | $1,001 – $15K | Sep 9, 2026 traded Aug 19, 2026 |
| 20 | Wassil JimEVP, Chief Scientific Ofc, COO |  PCVXVaxcyte, Inc.Open-market sale | SELL | $79K 1,334 sh | Sep 9, 2026 traded Sep 9, 2026 |
| 20 | Azamian Bobak R.Director, President/CEO and Board Chair | TARSTarsus Pharmaceuticals, Inc. Open-market sale · 10b5-1 plan | SELL | $641K 7,100 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 20 | Chen Sean ChihhsiangPresident and COO |  AMBQAmbiq Micro, Inc.Open-market sale · 10b5-1 plan | SELL | $123K 2,126 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 20 | Pfeiffer DeborahEVP & Pres, Presort Services |  PBIPITNEY BOWES INC /DE/Open-market sale · 10b5-1 plan | SELL | $342K 20.0K sh | Sep 9, 2026 traded Sep 8, 2026 |
| 20 | April McClain DelaneyDDependent child | TDYTELEDYNE TECHNOLOGIES INC Sale | SELL | $15K – $50K | Sep 9, 2026 traded Aug 25, 2026 |
| 20 | April McClain DelaneyDDependent child |  MLMMARTIN MARIETTA MATERIALS INCPurchase | BUY | $1,001 – $15K | Sep 9, 2026 traded Aug 19, 2026 |
| 20 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner |  PACSPACS Group, Inc.Open-market sale · 10b5-1 plan | SELL | $974K 22.8K sh | Sep 9, 2026 traded Sep 4, 2026 |
| 19 | Engelhardt Eva AnetteEVP, President, CDG |  BIOBIO.BBIO-RAD LABORATORIES, INC.Option exercise | M | — 1,027 sh | Sep 9, 2026 traded Sep 5, 2026 |
| 19 | Scheiwer Mark JEVP, CFO & CAO |  SMGSCOTTS MIRACLE-GRO COGrant or award | A | — 47 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 19 | Allison SchwartzDirector | BIOBIO.BBIO-RAD LABORATORIES, INC. Tax withholding | F | $32K 82 sh | Sep 9, 2026 traded Sep 5, 2026 |
| 19 | Mulshine Brendan MartinCo-President and CRO |  RYANRYAN SPECIALTY HOLDINGS, INC.Derivative conversion | C | — 40.0K sh | Sep 9, 2026 traded Sep 4, 2026 |
| 19 | McMahon Stephen AEVP, Chief Customer Officer |  DTDynatrace, Inc.Option exercise | M | — 5,821 sh | Sep 9, 2026 traded Sep 5, 2026 |
| 19 | Allison SchwartzDirector | BIOBIO.BBIO-RAD LABORATORIES, INC. Option exercise | M | — 228 sh | Sep 9, 2026 traded Sep 5, 2026 |
| 19 | Zugelder DanEVP, Chief Revenue Officer | DTDynatrace, Inc. Option exercise | M | — 3,220 sh | Sep 9, 2026 traded Sep 5, 2026 |
| 19 | Higgins John GerardChief, Client &Partner Success | PEGAPEGASYSTEMS INC Option exercise | M | — 1,616 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 19 | Carr DouglasSVP Finance & Operations |  IPSCCentury Therapeutics, Inc.Open-market sale | SELL | $521 254 sh | Sep 9, 2026 traded Sep 8, 2026 |
| 19 | Budur KumarCHIEF MEDICAL OFFICER | HRMYHarmony Biosciences Holdings, Inc. Option exercise | M | $326K 10.8K sh | Sep 9, 2026 traded Sep 8, 2026 |
| 19 | Yates Daniel S.SVP, Chief Accounting Officer | DTDynatrace, Inc. Option exercise | M | — 718 sh | Sep 9, 2026 traded Sep 5, 2026 |
| 19 | Allison SchwartzDirector | BIOBIO.BBIO-RAD LABORATORIES, INC. Option exercise | M | — 92 sh | Sep 9, 2026 traded Sep 6, 2026 |